- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02380833
Effectiveness of a Paleolithic Based Diet Compared to MyPlate Guidelines, With and Without Exercise, in Women.
November 15, 2016 updated by: Elliot D. Jesch, Clemson University
The Effectiveness of a Paleolithic Based Diet Compared to MyPlate Guidelines, With and Without Exercise, on Physical Conditioning in Women: a Randomized Controlled Trial.
The purpose of this study is to determine the effectiveness of recommending either a Paleolithic based diet or the United States Department of Agriculture MyPlate guidelines with or without exercise on physical conditioning, hormones related to energy metabolism, body composition, resting energy expenditure, blood biomarkers, and urine in young, adult females.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Clemson, South Carolina, United States, 29631
- Clemson University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- body fat percent between 20 and 38
- less than 150 minutes of exercise per week at 4.5 or greater Metabolic Equivalent of Task
- not pregnant, trying to become pregnant or lactating
- non-smoker
- no previous resistance training
- have not been on a diet in the past three months
- no dietary restrictions (food allergies, disease conditions, etc)
- have not lost more than 10 lbs. in the past three months
Exclusion Criteria:
- taking any medication
- women who have had a left breast mastectomy
- do not meet criteria of PAR-Q
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: MyPlate
To consume a weight maintenance diet based on the United States Department of Agriculture MyPlate nutrition recommendations for eight weeks.
|
To consume a weight maintenance diet based on the United States Department of Agriculture MyPlate nutrition recommendations for eight weeks.
|
|
Active Comparator: MyPlate + Exercise
To consume a weight maintenance diet based on the United States Department of Agriculture MyPlate nutrition recommendations and aerobic and resistance training four days per week for eight weeks.
|
To consume a weight maintenance diet based on the United States Department of Agriculture MyPlate nutrition recommendations and aerobic and resistance training four days per week for eight weeks.
|
|
Active Comparator: Paleolithic
To consume a weight maintenance diet based on alternative (Paleolithic based) nutrition recommendations for eight weeks.
|
To consume a weight maintenance diet based on alternative (Paleolithic based) nutrition recommendations for eight weeks.
|
|
Active Comparator: Paleolithic + Exercise
To consume a weight maintenance diet based on alternative (Paleolithic based) nutrition recommendations and aerobic and resistance training four days per week for eight weeks.
|
To consume a weight maintenance diet based on alternative (Paleolithic based) nutrition recommendations and aerobic and resistance training four days per week for eight weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in aerobic conditioning
Time Frame: Baseline and 8 weeks
|
Peak oxygen consumption
|
Baseline and 8 weeks
|
|
Change in anaerobic power
Time Frame: Baseline and 8 weeks
|
Wingate anaerobic threshold
|
Baseline and 8 weeks
|
|
Change in strength
Time Frame: Baseline and 8 weeks
|
Chest press and leg press estimated one repetition maximum
|
Baseline and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in resting energy expenditure
Time Frame: Baseline and 8 weeks
|
24 hour kcal and respiratory quotient
|
Baseline and 8 weeks
|
|
Change in urine
Time Frame: Baseline and 8 weeks
|
Osmolality
|
Baseline and 8 weeks
|
|
Change in insulin (plasma)
Time Frame: Baseline and 8 weeks
|
Radioimmunoprecipitation assay
|
Baseline and 8 weeks
|
|
Change in glucagon (plasma)
Time Frame: Baseline and 8 weeks
|
Radioimmunoprecipitation assay
|
Baseline and 8 weeks
|
|
Change in ghrelin (plasma)
Time Frame: Baseline and 8 weeks
|
Total and active ghrelin; Radioimmunoprecipitation assay
|
Baseline and 8 weeks
|
|
Change in peptide YY 3-36 (plasma)
Time Frame: Baseline and 8 weeks
|
Radioimmunoprecipitation assay
|
Baseline and 8 weeks
|
|
Change in adiponectin (plasma)
Time Frame: Baseline and 8 weeks
|
Radioimmunoprecipitation assay
|
Baseline and 8 weeks
|
|
Change in leptin (plasma)
Time Frame: Baseline and 8 weeks
|
Radioimmunoprecipitation assay
|
Baseline and 8 weeks
|
|
Change in tumor necrosis factor alpha (plasma)
Time Frame: Baseline and 8 weeks
|
ELISA
|
Baseline and 8 weeks
|
|
Change in interleukin 6 (plasma)
Time Frame: Baseline and 8 weeks
|
ELISA
|
Baseline and 8 weeks
|
|
Change in undercarboxylated osteocalcin (plasma)
Time Frame: Baseline and 8 weeks
|
enzymeimmunoassay
|
Baseline and 8 weeks
|
|
Change in total cholesterol (plasma)
Time Frame: Baseline and 8 weeks
|
Colorimetric enzyme assay
|
Baseline and 8 weeks
|
|
Change in HDL cholesterol (plasma)
Time Frame: Baseline and 8 weeks
|
Colorimetric enzyme assay
|
Baseline and 8 weeks
|
|
Change in non-HDL cholesterol (plasma)
Time Frame: Baseline and 8 weeks
|
Calculated from triacylglycerol, total cholesterol and HDL cholesterol
|
Baseline and 8 weeks
|
|
Change in triacylglycerol (plasma)
Time Frame: Baseline and 8 weeks
|
Colorimetric enzyme assay
|
Baseline and 8 weeks
|
|
Change in non-esterified fatty acids (plasma)
Time Frame: Baseline and weeks
|
Colorimetric enzyme assay
|
Baseline and weeks
|
|
Change in glucose (plasma)
Time Frame: Baseline and 8 weeks
|
Colorimetric enzyme assay
|
Baseline and 8 weeks
|
|
Change in ketones (plasma)
Time Frame: Baseline and 8 weeks
|
Colorimetric enzyme assay
|
Baseline and 8 weeks
|
|
Change in fat mass
Time Frame: Baseline and 8 weeks
|
Dual energy x-ray absorptiometry
|
Baseline and 8 weeks
|
|
Change in fat free mass
Time Frame: Baseline and 8 weeks
|
Dual energy x-ray absorptiometry
|
Baseline and 8 weeks
|
|
Change in bone mass
Time Frame: Baseline and 8 weeks
|
Dual energy x-ray absorptiometry
|
Baseline and 8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in free living activity
Time Frame: Baseline and 8 weeks
|
Armband activity monitor worn on the upper left arm (METs)
|
Baseline and 8 weeks
|
|
Change in blood pressure
Time Frame: Baseline and 8 weeks
|
Systolic and diastolic blood pressure
|
Baseline and 8 weeks
|
|
Change in resting heart rate
Time Frame: Baseline and 8 weeks
|
Beats per minute
|
Baseline and 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2015
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
February 16, 2015
First Submitted That Met QC Criteria
March 2, 2015
First Posted (Estimate)
March 5, 2015
Study Record Updates
Last Update Posted (Estimate)
November 17, 2016
Last Update Submitted That Met QC Criteria
November 15, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- IRB2014-457
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.